Close monitoring is essential for depression and suicidal ideation during therapy
Common Concerns After GLP-1 Weight Loss Rapid weight loss can reduce fat volume and skin elasticity faster than the body can adapt, leading to concerns such as: Facial hollowing or a tired, aged appearance (Ozempic face) Loose or sagging skin of the face, neck, arms, abdomen, or thighs Deflated breasts or changes in breast shape Loss of body contour and definition Crepey or lax skin texture Our approach focuses on restoring volume, tightening skin, and refining contours, while maintaining natural, balanced results
Traditionally GLP-1(9-36) was considered inactive, however more recent studies indicate that GLP-1(9-36) can contribute to inhibiting glucagon secretion by inhibiting voltage-gated calcium channels through a GPCR mechanism, an effect which reduces the number of glucagon containing vesicles that are available for exocytosis, thereby contributing the the decrease in glucagon secretion (Figure 1)(Zheng et al, 2024)
Intramuscular injection typically causes sharper pain during injection, more bleeding afterward, and sometimes a dull ache that persists for hours
Their ingredients and effectiveness may be very different from actual GLP-1 agonist drugs, as they only hold natural ingredients and no medications